Turnstone Biologics Ownership | Who Owns Turnstone Biologics?
Turnstone Biologics Ownership Summary
Turnstone Biologics is owned by 19.97% institutional investors, 7.70% insiders, and 72.33% retail investors. Orbimed advisors is the largest institutional shareholder, holding 13.39% of TSBX shares.
TSBX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Turnstone Biologics | 19.97% | 7.70% | 72.33% |
Sector | Healthcare Stocks | 279.17% | 10.51% | -189.68% |
Industry | Biotech Stocks | 63.95% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Orbimed advisors | 3.10M | 13.39% | $1.27M |
Pfm health sciences, lp | 932.35K | 4.03% | $382.26K |
72 investment | 549.98K | 2.38% | $225.49K |
Millennium management | 38.86K | 0.17% | $15.93K |
Sectoral asset management | - | - | - |
Virtu financial | - | - | - |
Citigroup | - | - | - |
Goldman sachs group | - | - | - |
Fil | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
72 investment | 549.98K | 0.63% | $225.49K |
Orbimed advisors | 3.10M | 0.03% | $1.27M |
Pfm health sciences, lp | 932.35K | 0.03% | $382.26K |
Sectoral asset management | - | - | - |
Virtu financial | - | - | - |
Citigroup | - | - | - |
Millennium management | 38.86K | - | $15.93K |
Goldman sachs group | - | - | - |
Fil | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Pfm health sciences, lp | 932.35K | 0.03% | - |
Orbimed advisors | 3.10M | 0.03% | - |
72 investment | 549.98K | 0.63% | - |
Virtu financial | - | - | -14.81K |
Goldman sachs group | - | - | -20.52K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sectoral asset management | - | - | -517.65K |
Fil | - | - | -192.66K |
Citigroup | - | - | -61.41K |
Millennium management | 38.86K | - | -34.89K |
Goldman sachs group | - | - | -20.52K |
Sold Out
Holder | Change |
---|---|
Virtu financial | -14.81K |
Goldman sachs group | -20.52K |
Citigroup | -61.41K |
Fil | -192.66K |
Sectoral asset management | -517.65K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 4 | -85.71% | 4,620,451 | -58.36% | 19 | 0.86% | - | -100.00% | 1 | -83.33% |
Dec 31, 2024 | 28 | 16.67% | 11,096,493 | -3.03% | 48 | 1.95% | 13 | 85.71% | 6 | -40.00% |
Sep 30, 2024 | 24 | -45.45% | 11,443,046 | -9.91% | 49 | 1.63% | 7 | -73.08% | 10 | -16.67% |
Jun 30, 2024 | 44 | 10.00% | 12,701,707 | -4.85% | 55 | 1.64% | 26 | 8.33% | 12 | 50.00% |
Mar 31, 2024 | 40 | 11.11% | 13,349,616 | 2.53% | 58 | 0.46% | 24 | 50.00% | 8 | -11.11% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $2.37M |
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $180.34K |
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $78.90K |
Jul 25, 2023 | Versant Ventures V, LLC | - | Buy | $71.27K |
Jul 20, 2023 | ORBIMED ADVISORS LLC | Buy | $5.00M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
2023 Q3 | 5 | - |
TSBX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools